临床研究

基于心电图参数、犬尿氨酸代谢物建立精神分裂症共患心血管疾病的列线图模型

  • 郭蕊 ,
  • 刘涛 ,
  • 苏玺
展开
  • 1.新乡医学院第二附属医院(河南省精神病医院),电生理科,(河南 新乡 453002 )
    2.新乡医学院第二附属医院(河南省精神病医院),重点实验室,(河南 新乡 453002 )

收稿日期: 2025-01-08

  网络出版日期: 2025-04-30

基金资助

河南省医学科技攻关计划省部共建项目(SBGJ202103094)

Establishment of a nomogram model for comorbid cardiovascular disease in schizophrenia based on electrocardiogram parameters and kynurenine metabolites

  • Rui GUO ,
  • Tao LIU ,
  • Xi. SU
Expand
  • Department of Electronic Science,the Second Affiliated Hospital of Xinxiang Medical College (Henan Psychiatric Hospital),Xinxiang 453002,Henan,China

Received date: 2025-01-08

  Online published: 2025-04-30

摘要

目的 探讨精神分裂症共患心血管疾病影响因素,并构建列线图模型。 方法 回顾性收集2023年6月至2024年10月医院586例精神分裂症患者临床资料,包含100例共患心血管疾病,486例未共患心血管疾病,分别设为共患组(n = 100)和非共患组(n = 486),采用倾向性评分匹配法(PSM)降低组间偏倚。统计两组临床资料、心电图参数[经心率校正的QT(QTc)、经心率校正的Tp-Te间期(TP-Tec)]、犬尿氨酸(KYN)代谢物[色氨酸(TRP)、KYN、犬尿喹啉酸(KYNA)],采用logistic回归方程筛选精神分裂症共患心血管疾病影响因素,构建列线图模型并验证。 结果 (1)BMI、吸烟、饮酒、睡眠障碍、QTc、TP-Tec、TRP、KYN、KYNA均是精神分裂症共患心血管疾病的高危因素(P < 0.05);(2)列线图模型诊断AUC为0.876,诊断结果与观察结果之间具有较好一致性;阈概率为5% ~ 100%时,患者净获益率较高。 结论 基于QTc、TP-Tec、TRP、KYN、KYNA等构建的列线图模型有助于提高精神分裂症共患心血管疾病诊断价值,指导临床诊治,降低心血管疾病。

本文引用格式

郭蕊 , 刘涛 , 苏玺 . 基于心电图参数、犬尿氨酸代谢物建立精神分裂症共患心血管疾病的列线图模型[J]. 实用医学杂志, 2025 , 41(8) : 1205 -1211 . DOI: 10.3969/j.issn.1006-5725.2025.08.017

Abstract

Objective To explore the factors influencing comorbid cardiovascular disease in schizophrenia and to construct a column-line graphical model. Methods Clinical data of 586 schizophrenic patients in the hospital from June 2023 to October 2024 were retrospectively collected. The study included 100 patients with comorbid cardiovascular disease and 486 patients without co-morbid cardiovascular disease, which were divided into the comorbidity group (n = 100) and the non-comorbidity group (n = 486). Propensity score matching (PSM) was used to reduce between-group bias. The clinical data, electrocardiogram parameters [QT corrected by heart rate (QTc), Tp-Te interval corrected by heart rate (TP-Tec)], and Kynurenine (KYN) metabolites [tryptophan (TRP), KYN, and kynurenic acid (KYNA)] were statistically analyzed in both groups. Logistic regression equation was used to screen the influencing factors of comorbid cardiovascular disease in schizophrenia. A nomogram model was constructed and validated. Results (1) BMI, smoking, alcohol consumption, sleep disorders, QTc, TP-Tec, TRP, KYN, and KYNA were all high-risk factors for co-morbid cardiovascular disease in schizophrenia (P < 0.05). (2) The diagnostic AUC for the nomogram model was 0.876, and there was a good concordance between diagnostic and observational results; and the threshold probability of a net patient benefit was higher when the threshold probability was between 5% and 100%. Conclusion The nomogram model constructed based on QTc, TP-Tec, TRP, KYN, KYNA, etc. can help improve the diagnostic value of schizophrenia comorbid cardiovascular disease, guide clinical diagnosis and treatment, and reduce cardiovascular disease.

参考文献

1 刘娜,王天道,余春柳,等. 精神分裂症患者血清催乳素和胶质纤维酸性蛋白与预后的关系[J]. 实用医学杂志,2023,39(16):2090-2094.
2 GEBREEGZIABHERE Y, HABATMU K, MIHRETU A,et al.Cognitive impairment in people with schizophrenia: An umbrella review[J]. Eur Arch Psychiatry Clin Neurosci,2022,272(7):1139-1155. doi:10.1007/s00406-022-01416-6
3 HAGI K, NOSAKA T, DICKINSON D,et al. Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia:A Systematic Review and Meta-analysis[J].JAMA Psychiatry,2021,78(5):510-518. doi:10.1001/jamapsychiatry.2021.0015
4 SALMINEN A. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: Role of tryptophan metabolites generated by gut host-microbiota[J]. J Mol Med (Berl),2023,101(3):201-222. doi:10.1007/s00109-023-02289-5
5 STIEGER A, HUBER M, YU Z R,et al. Association of Indoleamine 2,3-Dioxygenase (IDO) Activity with Outcome after Cardiac Surgery in Adult Patients[J]. Metabolites,2024,14(6):334. doi:10.3390/metabo14060334
6 ZAHID M U, KIRANYAZ S, GABBOUJ M. Global ECG Classification by Self-Operational Neural Networks With Feature Injection[J]. IEEE Trans Biomed Eng,2023,70(1):205-215. doi:10.1109/tbme.2022.3187874
7 HASAN A, FALKAI P, WOBROCK T,et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia-a short version for primary care[J]. Int J Psychiatry Clin Pract,2017,21(2):82-90. doi:10.1080/13651501.2017.1291839
8 VOLPE M, GALLO G, MODENA M G,et al. Updated Recommendations on Cardiovascular Prevention in 2022:An Executive Document of the Italian Society of Cardiovascular Prevention[J].High Blood Press Cardiovasc Prev,2022,29(2):91-102. doi:10.1007/s40292-021-00503-4
9 KANG Z W, QIN Y, SUN Y T,et al. Multigenetic Pharmacogeno-mics-Guided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia:A Randomized Clinical Trial[J]. JAMA Netw Open,2023,6(10):e2335518. doi:10.1001/jamanetworkopen.2023.35518
10 AL-TWEIGERI T, DENT S, SAYED A AL,et al. Using the Appropriate Formula for QT Measurement Can Save Lives[J]. Hematol Oncol Stem Cell Ther,2022,15(1):79-82. doi:10.1016/j.hemonc.2021.06.001
11 VALENZUELA P L, SANTOS-LOZANO A, SACO-LEDO G,et al.Obesity, cardiovascular risk, and lifestyle: Cross-sectional and prospective analyses in a nationwide Spanish cohort[J]. Eur J Prev Cardiol,2023,30(14):1493-1501. doi:10.1093/eurjpc/zwad204
12 刘丹, 苗加伟, 谭子豪, 等. 柚皮苷对心血管疾病的药理作用研究进展[J]. 中国临床药理学与治疗学, 2025, 30(2): 272-281.
13 SCHOOLING C M, ZHAO J V.Insights into Causal Cardiovascular Risk Factors from Mendelian Randomization[J]. Curr Cardiol Rep, 2023,25(2):67-76. doi:10.1007/s11886-022-01829-8
14 HUYNH P, HOFFMANN J D, GERHARDT T,et al. Myocardial infarction augments sleep to limit cardiac inflammation and damage[J]. Nature, 2024,635(8037):168-177. doi:10.1038/s41586-024-08100-w
15 ZHU W, HUANG X M, MEI L L,et al.The predictive value of Tp-Te interval,Tp-Te/QT ratio,and QRS-T angle of idiopathic ventricular tachycardia in patients with ventricular premature beats[J]. Clin Cardiol, 2023,46(4):425-430. doi:10.1002/clc.23998
16 MORI?A-VáZQUEZ P, MORALEDA-SALAS M T, LóPEZ-MASJUAN-RíOS á,et al. Improvement in electrocardiographic parameters of repolarization related to sudden death in patients with ventricular dysfunction and left bundle branch block after cardiac resynchronization through His bundle pacing[J]. J Interv Card Electrophysiol, 2023,66(9):2003-2010. doi:10.1007/s10840-023-01526-8
17 李东霞,梁直厚. 长期住院精神分裂症患者心电图QTc间期延长的影响因素分析[J]. 临床精神医学杂志, 2023,33(4):257-261.
18 姚丽红,王亚亚,张媛. AMI并发室性心律失常患者QTc,Tp-Tec间期变化及其与心功能的相关性[J]. 分子诊断与治疗杂志,2023,15(12):2075-2078.
19 苏杭,刘思丽,吴婕. 急性心肌梗死并发室性心律失常及心室重构患者12导联同步心电图监测及预后分析[J]. 海南医学,2023,34(2):180-184.
20 PIRZADA A, CAI J, CORDERO C,et al. Risk Factors for Cardiovascular Disease:Knowledge Gained from the Hispanic Community Health Study/Study of Latinos[J]. Curr Atheroscler Rep,2023,25(11):785-793. doi:10.1007/s11883-023-01152-9
21 R?DEVAND L, RAHMAN Z, HINDLEY G F L,et al. Characterizing the Shared Genetic Underpinnings of Schizophrenia and Cardiovascular Disease Risk Factors[J]. Am J Psychiatry, 2023,180(11):815-826. doi:10.1176/appi.ajp.20220660
22 HAJSL M, HLAVACKOVA A, BROULIKOVA K,et al. Tryptophan Metabolism,Inflammation,and Oxidative Stress in Patients with Neurovascular Disease[J]. Metabolites, 2020,10(5):208. doi:10.3390/metabo10050208
23 JAVANI G, BABRI S, FARAJDOKHT F,et al. Mitotherapy restores hippocampal mitochondrial function and cognitive impairment in aged male rats subjected to chronic mild stress[J]. Biogerontology, 2023,24(2):257-273. doi:10.1007/s10522-022-10014-x
24 NORI P, HAGHSHENAS R, AFTABI Y,et al. Comparison of moderate-intensity continuous training and high-intensity interval training effects on the Ido1-KYN-Ahr axis in the heart tissue of rats with occlusion of the left anterior descending artery[J]. Sci Rep, 2023,13(1):3721. doi:10.1038/s41598-023-30847-x
25 刘洋洋,张帅奇,刘佩,等. 基于机器学习模型探索节点综合拓扑属性在精神分裂症研究中的应用价值[J]. 中华神经医学杂志, 2024,23(7):705-710.
26 NIU X Q, CAO J Q. Predicting lymph node metastasis in colorectal cancer patients: Development and validation of a column chart model[J]. Updates Surg, 2024,76(4):1301-1310. doi:10.1007/s13304-024-01884-6
27 HJORT N L, STOLTENBERG E A. The partly parametric and partly nonparametric additive risk model[J]. Lifetime Data Anal,2023,29(2):372-402. doi:10.1007/s10985-021-09535-3
文章导航

/